Background Assessing the burden of COVID-19 on the basis of medically attended case
numbers is suboptimal given its reliance on testing strategy, changing case definitions, and …

The infection fatality risk (IFR) is the average number of deaths per infection by a pathogen
and is key to characterising the severity of infection across the population and for specific …

Objectives To validate the diagnostic accuracy of a Euroimmun SARS-CoV-2 IgG and IgA
immunoassay for COVID-19. Methods In this unmatched (1:2) case-control validation study, we …

Objective To determine whether pharmacogenetic tests such as N-acetyltransferase 2 (NAT2)
and cytochrome P450 2E1 (CYP2E1) genotyping are useful in identifying patients prone to …

Objectives To evaluate longitudinally the persistence of humoral immunity for up to 6 months
in a cohort of hospital employees with mild coronavirus disease 2019 (COVID-19). Methods …

The pathogenesis of acute myocardial infarction is known to be mediated by systemic,
intraplaque and myocardial inflammatory processes. Among different immune cell subsets, …

Aims Proprotein convertase subtilisin kexin 9 (PCSK9) is an emerging target for the treatment
of hypercholesterolaemia, but the clinical utility of PCSK9 levels to guide treatment is …

Aims The chemokine CCL5 plays a critical role as neutrophil and macrophage activator do
in atherosclerosis and myocardial infarction. Thus, we investigated whether the treatment …

Understanding the risk of infection from household- and community-exposures and the
transmissibility of asymptomatic infections is critical to SARS-CoV-2 control. Limited previous …

Background Up-to-date seroprevalence estimates are critical to describe the SARS-CoV-2
immune landscape and to guide public health decisions. Aim We estimate seroprevalence of …